Hologic stock holds near USD 76 after recall scrutiny

Published on 09/15/2026 at 16:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hologic stock traded at USD 76.01 on September 13, 2026. The latest quarter showed revenue and EPS rising year over year.

Aquarellgemälde eines modernen Medizintechnik-Campus mit Glasfassaden, Grünflächen und Pastellhimmel — Hologic Firmensitz in Aquarell mit Glasgebaeuden gruenen Wiesen und hellem Himmel ISIN US4364401012, Illustration mit AI erstellt.

Hologic stock (ISIN US4364401012) traded at USD 76.01 on Nasdaq on September 13, 2026, leaving the medical technology group with a multibillion-dollar market value and a share price near the middle of its 52-week band.

Recall risk meets earnings support

As ad hoc news reported on September 14, 2026, investors are still weighing an FDA Class II recall from April 2026 against Hologic's latest reported numbers. The same report said the most recent quarter within the past nine months showed revenue rising by a mid- to high-single-digit percentage year over year, while adjusted EPS also increased by a comparable rate.

The report also said the most recently completed fiscal year, ended within the past 24 months, delivered revenue growth in the mid-single-digit percentage range and EPS growth at a similar pace. That mix gives the stock a valuation floor, but it does not remove the regulatory overhang.

What the market is pricing

For investors, the key point is the gap between the USD 76.01 quote on September 13, 2026 and the narrative around recall risk. The shares were still described as trading in the mid-70 dollar range, with the market cap in the multibillion-dollar category.

Stock at USD 76.01

Hologic stock closed near USD 76.01 on September 13, 2026, after the session cited above. The quote sat roughly between the mid-60 dollar low zone and the low-80 dollar high zone of the 52-week range.